Need help?

Generic Pharmaceuticals Company Investment Opportunity in Surat, India

Pharmaceutical manufacturing company based in Surat with both local and international clients seeks investment.

Established 5-10 year(s)
Employees 50 - 100
Legal Entity Private Limited Company
Reported Sales USD 600 thousand
Run Rate Sales USD 1.5 million
EBITDA Margin 0 - 10 %
Industries Generic Pharmaceuticals
Locations  Surat
Local Time 6:16 PM Asia / Kolkata
Listed By Advisor / Business Broker
Status Active
Overall Rating
Seeking Investment
USD 9.5 million for 50.0% stake (Native Currency: INR 750,000,000)
Reason: Expansion of the Injectable line and investment for regulatory approvals.
Includes physical assets worth USD 16 million
Interested to connect with advisors
Name, Phone, Email
Available after connect
Business Name
Available after connect
User Verification
Documents
Business Overview

- Company manufactures generic pharmaceuticals for leading pharmaceutical companies.

- Has more than 20 clients across Asia, Middle East, Africa and America.

- Manufacturing capacity is 90,000 capsules per hour with latest equipment. Detailed capacities can be shared with interested parties upon introduction.

- Company is established with an objective to provide unique product propositions which meets the customer requirements and expectations.

- The unit is located at strategic location considering Gujarat a hub of various pharma giants. The existing manufacturing facility is equipped with latest technology for supreme manufacturing arrangement.

- It has all valid license in terms of sales and export and approvals from WHO and FDA.

- Company is a member of Pharmexcil (India) and Anti Microbial Resistance Industry Alliance (Switzerland).

- The high growth in sales compared to last year is due to various factors including better economic situation with respect to the pandemic, increase number of approvals, capacity and clients.

- Valuation is based on rapid growth rate and approvals. Company has applied for the European market approval which will open a door to new markets and client base. Company has the capacity to cater higher demands and requirements.

Products & Services Overview

Manufacturing of oral cephalosporin – tablet, hard gelatin capsule, dry syrup, direct compression granules.

Assets Overview

Physical assets include land, building, plant and machinery. Other assets are the software and regulatory approvals.

Facilities Overview

Company owns a 60,924 square feet facility built on a 86,110 square feet land.

Recent Activity
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct. Note that SMERGERS is not liable for any loss, damage, costs, claims and expenses whatsoever arising from transacting with any other user from the website. The final responsibility of conducting a thorough due diligence and taking the transaction forward lies with the users. Please read best practices on SMERGERS.
Contact Business

5 Investors already contacted this Business.
Register below to connect now!

Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct.
You might also be interested in these businesses

    Frequently
    Asked
    Questions

    • Why can’t I see the business’ name or contact number? How do I contact the business?
    • What level of due diligence does SMERGERS conduct on the businesses/member?
    • How active are the business profiles listed on SMERGERS?
    • How does SMERGERS rate business profiles?
    • Do I need to pay to connect with a business?
    • Show more